Decision-making processes among patients with lung cancer considering participation in neoadjuvant immunotherapy clinical trials: A qualitative grounded theory study
Authors:
- Man LiuMLMan Liu
- Lu LiuLLLu Liu
- Shuopeng JiaSJShuopeng Jia
- Dawei WuDWDawei Wu
- Yu TangYTYu Tang
- Shujun XingSXShujun Xing
Open Access
- 2 March 2026
- journal article
- Published by Elsevier in Asia-Pacific Journal of Oncology Nursing
- Vol. 13
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Shared decision-making and behaviour change collide: an analysis of consultations discussing clinical trial recruitmentTrials, 2025
- Patients' experiences of the decision‐making process for clinical trial participationNursing & Health Sciences, 2022
- Development of Immunotherapy Combination Strategies in CancerCancer Discovery, 2021
- Neoadjuvant immunotherapy for non–small cell lung cancer: State of the artCancer Communications, 2021
- Neoadjuvant Immunotherapy for NSCLC: Current Concepts and Future ApproachesJournal of Thoracic Oncology, 2020
- Changes in Strauss & Corbin's Grounded TheoryJournal of Korean Academy of Nursing, 2019
- Patients’ understanding of clinical research: An Italian cancer patient surveyTumori Journal, 2018
- Psychometric Evaluation of the Surrogate Decision Making Self-Efficacy ScaleResearch in Gerontological Nursing, 2013
- Problems for Judgment and Decision MakingAnnual Review of Psychology, 2001
- Clinical cancer research: An embattled speciesCancer, 1982